November 28th, 2012
No comments »
Anis Larbi, Iftikhar Alam and Tze Pin Ng have produced a truly provocative review article, Does Inflammation Determine Whether Obesity is Metabolically Healthy or Unhealthy? The Aging Perspective in Mediators of Inflammation. They start by addressing the fact that not all obesity is the same. Some adults with obesity can be metabolically healthy (MHO) while others are metabolically unhealthy (MUHO). The difference is the presence or absence of impaired glucose tolerance, dyslipidemia, hypercuricemia and hypertension. They note that obesity has spread around the world even as the exact causes of the obesity ‘pandemic’ are still in doubt. Additionally, they view obesity as a form of chronic inflammation. The inflammatory response is due to a number of components, including cytokines and adipokines.
The authors posit that, theoretically, metabolically healthy obese (MHO) and metabolically unhealthy obese (MUHO) humans “may represent distinct subtypes of obesity that were predetermined genetically to confer different metabolic and cardiovascular risks. Another theoretical possibility is that MHO and MUHO represent transitions phases from nonobesity in the development and natural history of obesity, with MHO individuals eventually turning into MUHO. It is tempting to think over the possibility of the other way round, that is, the possibility of converting MUHO into MHO. Whether MHO or MUHO is sustained or not for substantially a longer period may depend upon a number of factors, including the levels of cytokines and/or adipokines.” They call for studies to investigate of this transition from MHO to MUHO. “The answer to this question,” they note, “may have paramount clinical and public health implications. Once the temporal is established, the course of obesity can be stopped or delayed at some stage in its natural history before it becomes “metabolically unhealthy.”
They suggest that the elderly be the focus of such studies for a number of reasons, while noting that the BMI alone, as a sole indicator of obesity, is responsible for discrepant findings. (No argument here). They also point out that in one study, inflammation could be a key factor in causing obesity-induced type 2 diabetes. Gestational diabetes is also associated with chronic subclinical inflammation.
November 28th, 2012
No comments »
The Center for Disease Control and Prevention (CDC) has reported that the prevalence of diagnosed diabetes has increased in all US states, the District of Columbia and Puerto Rico between 1995 and 2010. The prevalence increased by 50% or more in 42 states and by 100% or more in 18 states. The states with the largest increases were Oklahoma, Kentucky, Georgia, Alabama and Washington. According to the CDC press release, in 1995 only 3 states had diagnosed diabetes prevalence of 6% or more; by 2010, all 50 states had a prevalence over 6%.
The press release, (rather amazingly to my point of view) states, “Type 2 diabetes, which may be prevented through lifestyle changes, accounts for 90 percent to 95 percent of all diabetes cases in the United States. CDC and its partners are working on a variety of initiatives to prevent type 2 diabetes and to reduce complications in those already diagnosed. CDC leads the National Diabetes Prevention Program, a public-private partnership that brings evidence-based programs for preventing type 2 diabetes to communities. The program is helping to establish a network of lifestyle-change classes for overweight or obese people at high risk of developing type 2 diabetes.” Of course the evidence-based program they refer to are the Diabetes Prevention Program, which found lifestyle prevention was only effective in young retirees and the Look AHEAD trial, which was terminated prematurely because the lifestyle group had no better outcomes than the control group. Why does the CDC continue to hype bang-the- lifestyle-drum when they know it doesn’t work?
October 20th, 2012
No comments »
The Obesity Paradox refers to the phenomenon that obesity appears to be protective after an initial heart attack. (Some researchers believe that the inaccuracies in the BMI are responsible for the perceived differences PubMed: Body Composition and survival in stable coronary heart disease.) Now comes a study from W. Doehner and colleagues at the Center for Stroke Research in Berlin, Germany. They found that the risk of mortality from a stroke or TIA was lower in overweight patients and lowest in obese patients compared to patients with a normal BMI. Obese patients had a lower risk of death or institutional care, death or high dependency, and death or recurrent stroke. Underweight patients had consistently the highest risks for all endpoints. PubMed: Overweight and obesity are associated with improved survival
The study from Germany did not evaluate consumption of dark chocolate. An UK study found consuming 20 grams of dark chocolate a day decreased systolic and diastolic blood pressure. PubMed: Differential effect of polyphenol-rick dark chocolate on biomarkers (Editor’s note: We need more studies like this!)
October 14th, 2012
No comments »
MC Otterstatter and colleagues have reported an increase in esophageal cancer in Canada. While rare, the incidence of esophageal adenocarcinoma has doubled in the past 20 years, probably reflecting the increasing prevalence of obesity and gastroesophageal reflux disease. PubMed: Esophageal cancer in Canada: Trends
May 19th, 2012
No comments »
The increasing prevalence of autism spectrum disorders (ASD) has been both controversial and concerning to parents and health professionals. Could obesity and type 2 diabetes be responsible for some of the increase?
In a paper in the May 2012 Pediatrics, researchers from the CHARGE (Childhood Autism Risks from Genetics and Environment) study in California, looked to see if metabolic conditions, specifically type 2 diabetes, hypertension and obesity, in mothers during pregnancy were associated with ASD or developmental delays (DD) in offspring. The study involved 517 children with ASD, 172 DD, and 315 controls. The researchers found that all metabolic conditions were more prevalent among mothers with affected children. Collectively, these conditions were associated with a higher likelihood of risk of ASD and DD relative to controls (odds ratio 1.61 and 1.10, respectively).
The authors state, “In a diabetic and possibly prediabetic pregnancy, poorly regulated maternal glucose can result in adverse fetal development. “ Concluding, they point out, “The prevalence of obesity and diabetes among US women of childbearing age is 34% and 8.7% respectively. Our findings raise concerns that these maternal conditions may be associated with neurodevelopmental problems in children and therefore could have serious public health implications. PubMed: Maternal Metabolic Conditions
May 17th, 2012
No comments »
Last week I provided my prepared statement on the relationship on obesity and cancer. Now comes a study of blood cancers among 578,000 adults showing body mass index (BMI) was associated with blood cancer risk, lymphoid neoplasms and Hodgkin’s lymphoma in women, and B-cell lymphoma and chronic lymphatic leukemia in men. BMI was the most consistent risk factor compared to other metabolic factors, especially for women. PubMed: Metabolic factors and blood cancer
Another study, out of Israel, has found that overweight in adolescence is related to increased risk of future urothelial cancer. PubMed:Overweight in adolescence and Urothelial
May 15th, 2012
No comments »
I testified last week at the FDA AdCom on lorcaserin. I prepared my testimony to talk about cancer in humans, rather than cancer in rats, which I knew would be the topic of the meeting. I didn’t deliver all of the following testimony. I only had about 4 minutes so I go through about half.
M. Downey Prepared statement before Endocrinologic and Metabolic Advisory Committee on lorcaserin, May 10, 2010.
Mr. Chairman, thank you for this opportunity to appear before the Advisory Committee. I have no financial relationship with the sponsor and no one paid for my participation at this hearing.
This morning we learned a lot about tumors in rats. Thank you. I learned a lot. Over several years, the committee has discussed the health effects of obesity but I do not recall many discussions about the effects of obesity on human cancer. I have three quick points:
-
Obesity/low physical activity is associated with increased risk of cancer in both men and women
-
Mechanisms of action in different cancers is unknown
-
Weight management appears useful for cancer survivors
Mortality
One study, using NCI Surveillance, Epidemiology, and End Results (SEER) data, estimated that in 2007 in the United States, about 34,000 new cases of cancer in men (4 percent) and 50,500 in women (7 percent) were due to obesity. Recent studies indicate that obesity and being overweight may increase the risk of death from many cancers, accounting for up to 14 percent of cancer deaths in men and 20 percent of cancer deaths in women. NCI:Fact Sheet:Obesity
Epidemiology
Not only is obesity increasing, the normal weight population is totally collapsing. This is an unique change in human physiology.
This is the graph of changes in the US from 1971 to 2008.
However, new projections show that in two decades, the overweight/obese population will increase by 33% and the severe/morbidly obese population will increase by a staggering 138%, according to a new publication by Finkelstein and colleagues at RTI and CDC. AJPM:Finkelstein:Projections_2030
According to the Annual Report to the Nation on the Status of Cancer:
-
Considerable evidence suggests that excess weight may be associated with increased risk of other cancers, including gallbladder, liver, thyroid, and hematopoietic cancers.
-
Lack of physical activity is associated with increased risk of colon, endometrial and postmenopausal and maybe premenopausal breast cancer.
Excess weight is associated with poorer survival among patients with breast cancer and colorectal cancer.” Eheman C, et al Annual Report to the Nation on the Status of Cancer, 1975-2008, Cancer 2012 May 1;118(9):2338-66
The connection between obesity and cancer have been attributed to:
-
Hormones
-
Growth Factors
-
Inflammation
However, no definitive path of causality has been established.
A study by Ma and colleagues has found starkly increased death rates due to cancer, as well as cardiovascular disease, in a large cohort of 112,000 Americans aged 18-39, followed for 16 years. Ma J, et al,
But obesity does not appear to have a blanket effect on all types of cancers, nor to affect cancer risk the same in men and women. One study found that obesity increases the risk of dying from all cancers by about 52% in men, but nearly doubled the risk of dying from any type of cancer in women.” PubMed:Calle_2003
In 2011, the Institute of Medicine National Cancer Policy Forum held a workshop on the impact of obesity on cancer survivorship, the general trend of the dialogue was that:
-
It is still an open question on recommending and implementing weight loss among cancer survivors
-
But sufficient evidence of general benefit of lower weight on health and increased risk of recurrence with obesity
-
Practical problems of cancers survivors attempting to lose weight.
Current research:
-
Imayama et al examined the effects of diet and exercise on inflammatory biomarkers in 439 postmenopausal women. The women were randomized to 1 year of caloric restriction diet, aerobic exercise or combined diet and exercise. Women in the diet and diet + exercise group with a 5% or more weight loss reduced inflammatory biomarkers compared with controls. The diet only and diet plus exercise groups showed reductions. Inflammation has been hypothesized to be a mechanism for cancer in obese patients. Cancer Research : Effect of Caloric Restriction
-
Last year, the same research team found that a combined diet and exercise intervention had positive effects on health related quality of life (HRQOL) in overweigh/obese postmenopausal women. Weight loss predicted improvements in physical functioning, vitality and mental health. Improved HRQOL led to positive changes in depression, stress and social support. PubMed: Dietary weight loss and exercise effect on HRQOL
-
A study published last November showed that a high body mass index BMI) at the time of diagnosis of breast cancer is associated with higher mortality, as is weight gain at later times. A low-fat diet rich in fruit, vegetables and fiber seems to be weakly associated with a better prognosis. There was no evidence of any benefit from micronutrients, supplements or antioxidant foods. Alcohol consumption did not affect outcomes in breast cancer. PubMed: Effect of overweight on breast cancer prognosis
-
Early stage overweight and obese endometrial cancer survivors randomized to 6 month lifestyle intervention or usual care. Adherence was 84%. Difference in weight at six months was -4.4kg and -4.6 at 12 months conclusion, behavior change and weight loss are achievable but clinical implications unclear. PubMed: Survivors of Uterine Cancer, SUCCEED Trial
-
A study published last November showed that a high body mass index BMI) at the time of diagnosis of breast cancer is associated with higher mortality, as is weight gain at later times. A low-fat diet rich in fruit, vegetables and fiber seems to be weakly associated with a better prognosis. There was no evidence of any benefit from micronutrients, supplements or antioxidant foods. Alcohol consumption did not affect outcomes in breast cancer. PubMed: Effect of overweight on breast cancer prognosis
-
Early stage overweight and obese endometrial cancer survivors randomized to 6 month lifestyle intervention or usual care. Adherence was 84%. Difference in weight at six months was -4.4kg and -4.6 at 12 months conclusion, behavior change and weight loss are achievable but clinical implications unclear. PubMed: Survivors of Uterine Cancer, SUCCEED Trial
-
A study published last November showed that a high body mass index BMI) at the time of diagnosis of breast cancer is associated with higher mortality, as is weight gain at later times. A low-fat diet rich in fruit, vegetables and fiber seems to be weakly associated with a better prognosis. There was no evidence of any benefit from micronutrients, supplements or antioxidant foods. Alcohol consumption did not affect outcomes in breast cancer. Hauner D, et al, The effect of overweight and nutrition on prognosis in breast cancer. Dtsch Arztebl Intl 2011 Nov. 108(47):795-801/ PubMed: Effect of overweight on breast cancer prognosis
-
Early stage overweight and obese endometrial cancer survivors randomized to 6 month lifestyle intervention or usual care. Adherence was 84%. Difference in weight at six months was -4.4kg and -4.6 at 12 months conclusion, behavior change and weight loss are achievable but clinical implications unclear. Von Gruenigen V et al, Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEES): A randomized controlled trial, Gyneco Oncol 2012 Mar 28 PubMed: Survivors of Uterine Cancer, SUCCEED Trial
May 3rd, 2012
No comments »
Huffman and colleagues looked at the American Health Association’s Strategic Impact Goals target of a 20% relative improvement in overall cardiovascular health. They looked at 35,000 cardiovascular disease-free adults in the NHANES surveys from 1999 to 2008. They found that the prevalence of smoking, hypercholesterolemia and hypertension declined, whereas the prevalence of obesity and dysglycemia increased through 2008. Projections to 2020 suggest that obesity and impaired fasting glucose/diabetes could increase to affect 43% and 77% of US men and 42% and 53% of US women. Overall, population level cardiovascular health is projected to improve only 6% overall, far below the AHA 20% target. PubMed: Cardiovascular Health Behaviors Changes and Projections